Clinical trial

Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"

NCT00222404 · University Hospital, Grenoble, Other · Completed

Key facts

NCT number NCT00222404
Title Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"
Official title Pharmacogenomic Study Realized Within the Framework of the Common Care to "Non-small Cell Lung Carcinoma" at Any Stages Treated by Chemotherapy.
Acronym Pharmacogenos
Lead sponsor University Hospital, Grenoble, Other
Collaborators Ministry of Health, France
Status Completed
Study type Observational
Conditions Carcinoma, Non-Small-Cell Lung
Enrollment 556
Start date Jul 1, 2005
Completion Aug 1, 2010
First posted Sep 22, 2005
Last update posted Nov 5, 2010
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies